Bios Equity COF, LP has filed 61 insider transactions across 1 company since August 2024.
Most recent transaction: a purchase of 71428 shares of ACTUATE THERAPEUTICS, INC. ($ACTU) on June 27, 2025.
Activity breakdown: 4 open-market purchases and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 27, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | P | Common Stock | 71428 | $7.00 | 10,196,456.0000 | 19,531,636 | 0.71% | 0.37% |
| June 27, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | P | Warrant (Right to Buy) | 71428 | $0.00 | 71,428.0000 | 19,531,636 | 9999.99% | 0.37% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | S | Common Stock | 5314 | $8.00 | 1,411,824.0000 | 0 | 0.37% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | S | Common Stock | 17361 | $8.00 | 1,411,824.0000 | 0 | 1.21% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | S | Common Stock | 2324 | $8.00 | 1,411,824.0000 | 0 | 0.16% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 884427 | $0.00 | 9,518,651.0000 | 0 | 10.24% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | P | Common Stock | 375000 | $8.00 | 9,893,651.0000 | 0 | 3.94% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | P | Common Stock | 125000 | $8.00 | 9,893,651.0000 | 0 | 1.28% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 525797 | $0.00 | 9,893,651.0000 | 0 | 5.61% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 307538 | $0.00 | 9,893,651.0000 | 0 | 3.21% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 141457 | $0.00 | 9,734,965.0000 | 0 | 1.47% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 462073 | $0.00 | 9,375,291.0000 | 0 | 5.18% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 61857 | $0.00 | 9,824,260.0000 | 0 | 0.63% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 153702 | $0.00 | 9,746,604.0000 | 0 | 1.60% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 54032 | $0.00 | 9,788,997.0000 | 0 | 0.56% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 176499 | $0.00 | 9,551,790.0000 | 0 | 1.88% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 23628 | $0.00 | 9,847,888.0000 | 0 | 0.24% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 147047 | $0.00 | 9,893,651.0000 | 0 | 1.51% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 101900 | $0.00 | 9,890,897.0000 | 0 | 1.04% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 332867 | $0.00 | 9,884,657.0000 | 0 | 3.48% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 44559 | $0.00 | 9,892,447.0000 | 0 | 0.45% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 309589 | $0.00 | 9,819,449.0000 | 0 | 3.26% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 2022029 | $0.00 | 9,409,013.0000 | 0 | 27.37% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 326547 | $0.00 | 9,815,384.0000 | 0 | 3.44% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 2094650 | $0.00 | 9,893,651.0000 | 0 | 26.86% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 74202 | $0.00 | 9,893,651.0000 | 0 | 0.76% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 484638 | $0.00 | 9,893,651.0000 | 0 | 5.15% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 78267 | $0.00 | 9,893,651.0000 | 0 | 0.80% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Common Stock | 573394 | $0.00 | 9,893,651.0000 | 0 | 6.15% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | X | Common Stock | 8068 | $5.27 | 9,898,965.0000 | 0 | 0.08% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | S | Common Stock | 5314 | $9.00 | 9,893,651.0000 | 0 | 0.05% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | X | Common Stock | 26355 | $5.27 | 9,911,012.0000 | 0 | 0.27% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | S | Common Stock | 17361 | $9.00 | 9,893,651.0000 | 0 | 0.18% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | X | Common Stock | 3528 | $5.27 | 9,895,975.0000 | 0 | 0.04% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | S | Common Stock | 2324 | $9.00 | 9,893,651.0000 | 0 | 0.02% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Convertible Note | 884427 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series A Redeemable Convertible Preferred Stock | 525797 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series A Redeemable Convertible Preferred Stock | 307538 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-1 Redeemable Convertible Preferred Stock | 141457 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-1 Redeemable Convertible Preferred Stock | 462073 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-1 Redeemable Convertible Preferred Stock | 61857 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-1 Redeemable Convertible Preferred Stock | 153702 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-2 Redeemable Convertible Preferred Stock | 54032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-2 Redeemable Convertible Preferred Stock | 176499 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-2 Redeemable Convertible Preferred Stock | 23628 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-2 Redeemable Convertible Preferred Stock | 147047 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-3 Redeemable Convertible Preferred Stock | 101900 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-3 Redeemable Convertible Preferred Stock | 332867 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-3 Redeemable Convertible Preferred Stock | 44559 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-4 Redeemable Convertible Preferred Stock | 309589 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-4 Redeemable Convertible Preferred Stock | 2022029 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-4 Redeemable Convertible Preferred Stock | 326547 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series B-4 Redeemable Convertible Preferred Stock | 2094650 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series C Redeemable Convertible Preferred Stock | 74202 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series C Redeemable Convertible Preferred Stock | 484638 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series C Redeemable Convertible Preferred Stock | 78267 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | C | Series C Redeemable Convertible Preferred Stock | 573394 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | X | Warrant (Right to Buy) | 8068 | $0.00 | 37,951.0000 | 0 | 17.53% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | X | Warrant (Right to Buy) | 26355 | $0.00 | 37,951.0000 | 0 | 40.98% | 0.00% |
| Aug. 14, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | X | Warrant (Right to Buy) | 3528 | $0.00 | 37,951.0000 | 0 | 8.51% | 0.00% |
| Aug. 12, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Bios Equity COF, LP | Director | A | Stock Options | 15000 | $0.00 | 46,884.0000 | 0 | 47.05% | 0.00% |